Zacks Research Forecasts Exelon’s Q3 Earnings (NASDAQ:EXC)

Exelon Co. (NASDAQ:EXCFree Report) – Zacks Research decreased their Q3 2024 earnings per share estimates for Exelon in a report released on Tuesday, October 29th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.67 for the quarter, down from their previous estimate of $0.68. The consensus estimate for Exelon’s current full-year earnings is $2.44 per share. Zacks Research also issued estimates for Exelon’s Q4 2024 earnings at $0.61 EPS, FY2024 earnings at $2.43 EPS, Q2 2025 earnings at $0.49 EPS, Q4 2025 earnings at $0.64 EPS, FY2025 earnings at $2.60 EPS, Q1 2026 earnings at $0.77 EPS, Q3 2026 earnings at $0.82 EPS and FY2026 earnings at $2.76 EPS.

Exelon (NASDAQ:EXCGet Free Report) last posted its quarterly earnings data on Thursday, August 1st. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.07. The company had revenue of $5.36 billion during the quarter, compared to analysts’ expectations of $4.98 billion. Exelon had a net margin of 10.65% and a return on equity of 9.40%. During the same period in the prior year, the company posted $0.41 earnings per share.

Other equities research analysts have also recently issued reports about the company. Scotiabank lifted their target price on Exelon from $37.00 to $40.00 and gave the stock a “sector perform” rating in a research note on Tuesday, August 20th. Jefferies Financial Group began coverage on Exelon in a research note on Thursday, September 19th. They set a “buy” rating and a $46.00 price objective on the stock. Barclays boosted their price target on shares of Exelon from $41.00 to $44.00 and gave the company an “overweight” rating in a research report on Tuesday, October 15th. UBS Group upped their price objective on shares of Exelon from $40.00 to $43.00 and gave the stock a “neutral” rating in a research report on Friday, September 20th. Finally, Morgan Stanley raised their price target on Exelon from $42.00 to $45.00 and gave the company an “equal weight” rating in a research report on Wednesday, September 25th. Eleven investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, Exelon presently has an average rating of “Hold” and a consensus price target of $41.33.

View Our Latest Report on Exelon

Exelon Price Performance

EXC opened at $39.55 on Wednesday. The firm’s fifty day moving average price is $39.59 and its two-hundred day moving average price is $37.67. The company has a market capitalization of $39.57 billion, a price-to-earnings ratio of 16.28, a P/E/G ratio of 2.90 and a beta of 0.53. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.03 and a quick ratio of 0.93. Exelon has a 1 year low of $33.35 and a 1 year high of $41.48.

Institutional Investors Weigh In On Exelon

Several hedge funds have recently modified their holdings of EXC. Vanguard Group Inc. raised its stake in Exelon by 16.3% in the first quarter. Vanguard Group Inc. now owns 105,310,761 shares of the company’s stock worth $3,956,525,000 after buying an additional 14,749,899 shares in the last quarter. Lazard Asset Management LLC raised its position in shares of Exelon by 112.4% in the 1st quarter. Lazard Asset Management LLC now owns 31,527,396 shares of the company’s stock worth $1,184,483,000 after acquiring an additional 16,686,526 shares in the last quarter. Jacobs Levy Equity Management Inc. lifted its stake in shares of Exelon by 2.4% during the 1st quarter. Jacobs Levy Equity Management Inc. now owns 4,887,035 shares of the company’s stock worth $183,606,000 after purchasing an additional 113,428 shares during the last quarter. CANADA LIFE ASSURANCE Co boosted its position in Exelon by 4.6% during the first quarter. CANADA LIFE ASSURANCE Co now owns 4,374,891 shares of the company’s stock valued at $164,623,000 after purchasing an additional 193,223 shares in the last quarter. Finally, Los Angeles Capital Management LLC grew its stake in Exelon by 666.2% in the second quarter. Los Angeles Capital Management LLC now owns 3,583,477 shares of the company’s stock valued at $124,024,000 after purchasing an additional 3,115,763 shares during the last quarter. Hedge funds and other institutional investors own 80.92% of the company’s stock.

Exelon Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 13th. Shareholders of record on Monday, November 11th will be issued a dividend of $0.38 per share. This represents a $1.52 annualized dividend and a yield of 3.84%. Exelon’s payout ratio is 62.55%.

Exelon Company Profile

(Get Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

See Also

Earnings History and Estimates for Exelon (NASDAQ:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.